Analysts at Morgan Stanley downgrade Auxilium Pharmaceuticals Inc AUXL from “overweight” to “equal weight.” The target price for AUXL has been lowered from $34 to $26.
AUXL shares gained 1.41% to close at $23.00 yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
